FOXP3 and neoplasm: In man, Tregs (CD4+ CD25+ FOXP3+ (Forkhead Box Protein 3)) have been documented in blood, lymph nodes, ascites and infiltrating the tumour microenvironment in a variety of solid cancers [11-16].